Here's what Keppel O&M needs to come back to black

Higher demand for gas vessels in two to three years could drive contract wins to $4b-$5b.

Keppel Offshore & Marine (Keppel O&M) is on the cusp of recovery, DBS Equity Research said, after it scored stronger order flows with $1.2b worth of new orders in 2017, up from $500m in 2016.

According to a report, the growth is expected to accelerate in 2018, with higher order win expectation of $3bn.

DBS analyst Pei Hwa Ho said, "We believe the pick-up in demand for O&G production-related facilities and Floating Liquefied Natural Gas (FLNG) vessels in the next two to three years could eventually drive contract wins closer to the norm of $4b-$5b per annum."

This would buck the declining trend of its current low order book of $3.9b.

The brokerage added that scrapping of old rigs over 30 years old, which constitutes about 15% of the current fleet globally, could help push the market back into balance.

An oil price rebound would also improve rig utilisation, spurring capex spending and order wins.

In terms of growth potential, Keppel’s first-mover advantage in the FLNG conversion market could provide earnings upside. Its customer Golar has already awarded Keppel a third FLNG project.  

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Top News

65LAB backs NUS biotech venture with $2.13m funding
The capital will help advance a treatment candidate for a chronic lung disease.
Healthcare
Seatrium wins ABS nod for offshore ammonia energy hub concept
The hub integrates ammonia fuel, power generation, and vessel charging.
Manulife IM Malaysia launches Singapore equity fund
The fund gives Malaysian investors exposure to Singapore equities amid market reforms aimed at improving liquidity.